Markéta Komlóová

Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage—Preparation, in vitro screening and molecular docking

Kamil Musílek, Markéta Komlóová, Ondřej Holas et al. · Bioorganic & Medicinal Chemistry · 2010 · 51 citations · Full text

Biochemistry, Medicine, Vitro Screening +8

Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage—initial study for Myasthenia gravis implications

Kamil Musílek, Markéta Komlóová, Vlasta Zavadova et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 41 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Myasthenia Gravis Implications +10

Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment

Markéta Komlóová, Kamil Musílek, Anna Horova et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 36 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +5

Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage – Implications for early Myasthenia gravis treatment

Kamil Musílek, Markéta Komlóová, Ondřej Holas et al. · European Journal of Medicinal Chemistry · 2010 · 34 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +7

N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules

Zuzana Rychtarčíková, Martin Krátký, Martin Gazvoda et al. · Molecules · 2014 · 21 citations · Full text